16 February 2022 Press releases

M&A transaction in the medical technology sector: GvW advises on the sale of EUROPIN to Gilde Healthcare

GvW Graf von Westphalen has advised the majority shareholder ConBrio Beteiligungen AG and the other minority shareholders of EUROPIN GmbH on the sale of the company to the private equity investor Gilde Healthcare.

EUROPIN develops and manufactures high-quality medical products such as pen needles and lancet needles. Headquartered in Heidelberg, the company is one of the European market leaders with an annual production of more than two billion needles.

With the takeover of EUROPIN, Gilde Healthcare has acquired another manufacturer of customised cannulas and cannula systems. The Dutch private equity investor recently invested in the German medical technology company Acti-Med. The merger will enable EUROPIN and Acti-Med to significantly expand their market presence and product portfolio.

GvW advised the shareholders through a Frankfurt team consisting of Dr Markus Sachslehner (lead), Jan Hüniken, Benjamin Schwarzfischer (all M&A) and Dr Michael Engel (tax). The head of the M&A practice group at GvW, Dr Markus Sachslehner, had already advised ConBrio Beteiligungen on the acquisition of the stake in EUROPIN.

Stay informed

You don't want to miss any more of the latest legal developments? And be invited to our events? Then register here.